Anti-IL17 x Anti-TNF Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-IL17 and anti-TNF parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can block two proinflammatory cytokines simultaneously. It is designed for the research of Rheumatoid arthritis (RA); Plaque psoriasis therapy.
There are currently no customer reviews or questions for Anti-IL17 x Anti-TNF Bispecific Antibody (IgG-IgG) (BSIG-175). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS